Nuvectis Pharma Inc (NVCT)

Feb 06, 2025

Nuvectis: Additional Data In Q2 Of 2025 Could Allow It To Stage A Comeback - Seeking Alpha

Feb 06, 2025

Feb 06, 2025

Nuvectis Pharma launches public stock offering - MSN

Feb 06, 2025

Feb 06, 2025

Nuvectis Pharma prices 2.7M shares at $5.00 in underwritten public offering - MSN

Feb 06, 2025

Feb 05, 2025

Nuvectis Pharma 2.7M share Spot Secondary priced at $5.00 - MSN

Feb 05, 2025

Feb 05, 2025

Nuvectis Pharma announces pricing of $13.5M public offering - MSN

Feb 05, 2025

Feb 05, 2025

Nuvectis Pharma Prices $13.5 Million Public Offering of Shares -February 05, 2025 at 10:52 am EST - Marketscreener.com

Feb 05, 2025

Feb 05, 2025

Nuvectis Pharma Prices of $13.5 Million Public Offering of Common Stock - citybiz

Feb 05, 2025

Feb 05, 2025

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock - GlobeNewswire

Feb 05, 2025

Feb 05, 2025

Nuvectis Secures Critical $13.5M Funding: Major Push for Revolutionary Cancer Drug Development - StockTitan

Feb 05, 2025

Feb 04, 2025

Nuvectis Pharma launches public stock offering By Investing.com - Investing.com South Africa

Feb 04, 2025

Feb 04, 2025

Nuvectis Pharma Announces Proposed Public Offering of Common Stock - GlobeNewswire

Feb 04, 2025

Feb 04, 2025

Nuvectis Pharma's Strategic Funding Move: Key Details on Oncology Pipeline Investment - StockTitan

Feb 04, 2025

Feb 01, 2025

(NVCT) Trading Signals - Stock Traders Daily

Feb 01, 2025

Jan 31, 2025

Critical Contrast: Evolus (NASDAQ:EOLS) and Nuvectis Pharma (NASDAQ:NVCT) - Defense World

Jan 31, 2025

Jan 27, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Bought by Baldwin Wealth Partners LLC MA - MarketBeat

Jan 27, 2025

Jan 22, 2025

How To Trade (NVCT) - Stock Traders Daily

Jan 22, 2025

Jan 12, 2025

Geode Capital Management LLC Has $501,000 Holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

Jan 12, 2025

Jan 11, 2025

(NVCT) Proactive Strategies - Stock Traders Daily

Jan 11, 2025

Jan 07, 2025

Nuvectis Pharma: Still Flat, Although There May Be A Ground Floor Here - Seeking Alpha

Jan 07, 2025

Jan 04, 2025

Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently - Yahoo Finance

Jan 04, 2025

Jan 01, 2025

(NVCT) Long Term Investment Analysis - Stock Traders Daily

Jan 01, 2025

Dec 29, 2024

Great week for Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders who have 63% stake and they haven’t stopped buying - Simply Wall St

Dec 29, 2024

Dec 27, 2024

Nuvectis Pharma CEO Ron Bentsur buys $20,925 in shares By Investing.com - Investing.com Australia

Dec 27, 2024

Dec 26, 2024

Nuvectis Pharma, Inc. (NASDAQ:NVCT) CEO Ron Bentsur Acquires 4,500 Shares - MarketBeat

Dec 26, 2024

Dec 26, 2024

Nuvectis Pharma CEO Ron Bentsur buys $20,925 in shares - Investing.com

Dec 26, 2024

Dec 20, 2024

Nuvectis Pharma stock hits 52-week low at $4.44 amid market challenges - Investing.com Australia

Dec 20, 2024

Dec 16, 2024

Marlio Charles Mosseri Purchases 17,000 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock - MarketBeat

Dec 16, 2024

Dec 16, 2024

Nuvectis pharma investor Mosseri-Marlio purchases $79,900 in shares By Investing.com - Investing.com

Dec 16, 2024

Dec 10, 2024

Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium - The Manila Times

Dec 10, 2024

Dec 05, 2024

NVCT Stock Hits 52-Week Low at $4.61 Amid Market Challenges - Investing.com

Dec 05, 2024

Nov 26, 2024

Wall Street Analysts Predict a 169.94% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know - MSN

Nov 26, 2024

Nov 25, 2024

Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - MSN

Nov 25, 2024

Nov 22, 2024

Nuvectis Pharma stock hits 52-week low at $4.7 amid market challenges - Investing.com Australia

Nov 22, 2024

Nov 22, 2024

Nuvectis Pharma stock hits 52-week low at $4.7 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 21, 2024

Nuvectis sinks after early-stage data for ovarian cancer therapy - MSN

Nov 21, 2024

Nov 21, 2024

Nuvectis pharma officer Enrique Poradosu buys $9,980 in stock By Investing.com - Investing.com Australia

Nov 21, 2024

Nov 21, 2024

Ron Bentsur Buys Handful Of Shares In Nuvectis Pharma - Simply Wall St

Nov 21, 2024

Nov 21, 2024

Insider Buying: Nuvectis Pharma Inc (NVCT) Chairman & CEO Acquires Shares - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Nuvectis pharma officer Enrique Poradosu buys $9,980 in stock - Investing.com

Nov 20, 2024

Nov 19, 2024

Vitalli ends work on Daewoong asset; Alector’s $50M loan - Endpoints News

Nov 19, 2024

Nov 18, 2024

Nuvectis Pharma, Inc. (NASDAQ:NVCT) CEO Ron Bentsur Buys 20,000 Shares - MarketBeat

Nov 18, 2024

Nov 18, 2024

Nuvectis pharma chairman buys $98,400 in common stock By Investing.com - Investing.com Canada

Nov 18, 2024

Nov 18, 2024

Nuvectis pharma chairman buys $98,400 in common stock - Investing.com

Nov 18, 2024

Nov 15, 2024

Nuvectis Pharma reports data from Phase 1b study of NXP800 - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Market Alert: Nuvectis Pharma reports promising data for NXP800 in Phase 1b; Advancing Towards Higher Dose Cohort - The Globe and Mail

Nov 14, 2024